Author:
Jiang Yiling,Bash Lori D.,Saager Leif
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference76 articles.
1. Robertson T, Ridge A. Proposal for update of the anaesthesia and muscle relaxant sections of the WHO; 18th Expert Committee on the Selection and Use of Essential Medicines. 2010. http://www.who.int/selection_medicines/committees/expert/18/applications/anaesthetic_proposal.pdf. Accessed 10 July 2019.
2. Wilcox SR, Bittner EA, Elmer J, et al. Neuromuscular blocking agent administration for emergent tracheal intubation is associated with decreased prevalence of procedure-related complications. Crit Care Med. 2012;40:1808–13.
3. Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg. 2010;111:120–8.
4. Murphy GS. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period. Minerva Anestesiol. 2006;72:97–109.
5. Belcher AW, Leung S, Cohen B, et al. Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005–2013: a single center study. J Clin Anesth. 2017;43:33–8.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献